Anika Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $190.3M
Liabilities Breakdown FY2025
Total Liabilities: $46.8M
Asset Breakdown
Total Assets: $190.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $57.5M | 30.2% |
| Accounts Receivable | $23.7M | 12.5% |
| Inventory | $18.8M | 9.9% |
| Property, Plant & Equipment | $40.3M | 21.2% |
| Goodwill | $8.1M | 4.2% |
| Intangible Assets | $1.7M | 0.9% |
| Other Assets | $40.3M | 21.2% |
Liabilities Breakdown
Total Liabilities: $46.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.0M | 12.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $40.8M | 87.1% |